Overview
Compare with ClearSign Combustion, Senseonics (United States) or SYPRIS SOLUTIONS INC, or pick any stock.
- TickerINIS on OTC1
- IndustryIndustrial Instruments For Measurement, Display, and Control1
- HeadquartersIdaho Falls, Idaho1
- Incorporated inTX2
- Business address4137 Commerce Circle, Idaho Falls, Id 834012
- Filer categoryNon-accelerated filer, Smaller reporting company2
See how the biggest companies compare on our leaderboards
Radnostix Inc. (the “Company”, “we”, “us” and “our”) manufactures a wide range of radioisotope-focused products used in variety of medical and industrial applications. We were formed as a Texas corporation in 1995. On December 23, 2025, we filed a Certificate of Amendment in the state of Texas for the sole purpose of amending our Certificate of Formation to change our corporate name from International Isotopes Inc. to Radnostix, Inc. Our board of directors approved the name change on October 21, 2025, and a majority of shareholders approved the name change by written consent on November 25, 2025.4 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Business segments
Theranostics Products brought in 52% of the revenue RADNOSTIX INC broke down this way in fiscal 2025.
Business segments by year
| Business segments | 2024 | 2025 |
|---|---|---|
| Theranostics Products | $8.0M | $6.8M |
| Calibration & Reference Products | $3.5M | $4.2M |
| Cobalt Products | $2.4M | $1.8M |
| Medical Device Products | $8.7K | $229.0K |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue41¢$5.4M
- Research and development3¢$435.8K
- Other costs56¢$7.3M
Out of $13.1M in revenue.5 The company lost money this year.
Where each dollar of operating cash went, fiscal 2025
- Capital spending86¢$534.2K
- Kept or used elsewhere14¢$86.0K
Out of $620.2K of cash from operations.5
Financial statements
Every line of the income statement as filed: the last 2 fiscal years, latest first.5
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Revenues | $13.1M | $13.9M |
| Cost of product | $5.4M | $5.3M |
| Gross profit | $7.7M | $8.6M |
| Salaries and contract labor | $4.5M | $4.0M |
| General, administrative, and consulting | $3.7M | $4.0M |
| Research and development | $435.8K | $610.7K |
| Total operating expenses | $8.7M | $8.6M |
| Operating profit (loss) | -$956.2K | $6.9K |
| Other income | $310.8K | $208.0K |
| Interest income | $76.6K | $122.4K |
| Interest expense | -$339.3K | -$328.7K |
| Total other (expense) income | $48.2K | $1.7K |
| Net income (loss) | -$908.0K | $8.6K |
| Net income (loss) per common share - basic: (in dollars per share) | $0.00 | $0.00 |
| Net income (loss) per common share - diluted: (in dollars per share) | $0.00 | $0.00 |
| Weighted average common shares outstanding - basic (in shares) | 526.8M shares | 522.3M shares |
| Weighted average common shares outstanding - diluted (in shares) | 526.8M shares | 522.3M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 3 fiscal years (annual) or 3 quarters (quarterly), latest first.5
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $1.7M | $1.9M | |
| Accounts receivable | $1.4M | $1.5M | |
| Inventories | $875.4K | $820.9K | |
| Prepaids and other current assets | $636.5K | $698.0K | |
| Total current assets | $4.6M | $5.0M | |
| Restricted cash | $1.5M | $1.4M | |
| Property, plant, and equipment, net | $3.7M | $3.3M | |
| Capitalized lease disposal costs, net | $590.1K | $639.3K | |
| Financing lease right-of-use asset | $0 | $826 | |
| Operating lease right-of-use asset | $2.8M | $2.0M | |
| Goodwill | $1.4M | $1.4M | |
| Patents and other intangibles, net | $3.2M | $3.4M | |
| Total long-term assets | $13.2M | $12.2M | |
| Total assets | $17.8M | $17.2M | |
| Accounts payable | $1.5M | $861.9K | |
| Accrued liabilities | $1.7M | $1.5M | |
| Unearned revenue | $388.9K | $513.3K | |
| Current portion of operating lease right-of-use liability | $187.0K | $150.5K | |
| Current portion of notes payable | $162.7K | $308.4K | |
| Total current liabilities | $4.0M | $3.3M | |
| Accrued long-term liabilities | $0 | $37.5K | |
| Asset retirement obligation | $1.6M | $1.5M | |
| Operating lease right-of-use liability, net of current portion | $2.7M | $1.9M | |
| Mandatorily redeemable convertible preferred stock | $4.1M | $4.1M | |
| Total long-term liabilities | $10.2M | $9.5M | |
| Total liabilities | $14.1M | $12.8M | |
| Common stock, $0.01 par value; 750,000,000 shares authorized; 528,209,538 and 523,553,435 shares issued and outstanding respectively | $5.3M | $5.2M | |
| Additional paid in capital | $126.6M | $126.4M | |
| Accumulated deficit | -$128.2M | -$127.3M | |
| Total equity | $3.7M | $4.3M | $4.0M |
| Total liabilities and stockholders' equity | $17.8M | $17.2M | |
| Common stock, par value (in dollars per share) | $0.01 | $0.01 | |
| Common stock, authorized (in shares) | 750.0M shares | 750.0M shares | |
| Common stock, issued (in shares) | 528.2M shares | 523.6M shares | |
| Common stock, outstanding (in shares) | 528.2M shares | 523.6M shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $1.7M | $1.9M | |
| Accounts receivable | $1.4M | $1.5M | |
| Inventories | $875.4K | $820.9K | |
| Prepaids and other current assets | $636.5K | $698.0K | |
| Total current assets | $4.6M | $5.0M | |
| Restricted cash | $1.5M | $1.4M | |
| Property, plant, and equipment, net | $3.7M | $3.3M | |
| Capitalized lease disposal costs, net | $590.1K | $639.3K | |
| Financing lease right-of-use asset | $0 | $826 | |
| Operating lease right-of-use asset | $2.8M | $2.0M | |
| Goodwill | $1.4M | $1.4M | |
| Patents and other intangibles, net | $3.2M | $3.4M | |
| Total long-term assets | $13.2M | $12.2M | |
| Total assets | $17.8M | $17.2M | |
| Accounts payable | $1.5M | $861.9K | |
| Accrued liabilities | $1.7M | $1.5M | |
| Unearned revenue | $388.9K | $513.3K | |
| Current portion of operating lease right-of-use liability | $187.0K | $150.5K | |
| Current portion of notes payable | $162.7K | $308.4K | |
| Total current liabilities | $4.0M | $3.3M | |
| Accrued long-term liabilities | $0 | $37.5K | |
| Asset retirement obligation | $1.6M | $1.5M | |
| Operating lease right-of-use liability, net of current portion | $2.7M | $1.9M | |
| Mandatorily redeemable convertible preferred stock | $4.1M | $4.1M | |
| Total long-term liabilities | $10.2M | $9.5M | |
| Total liabilities | $14.1M | $12.8M | |
| Common stock, $0.01 par value; 750,000,000 shares authorized; 528,209,538 and 523,553,435 shares issued and outstanding respectively | $5.3M | $5.2M | |
| Additional paid in capital | $126.6M | $126.4M | |
| Accumulated deficit | -$128.2M | -$127.3M | |
| Total equity | $3.7M | $4.3M | $4.0M |
| Total liabilities and stockholders' equity | $17.8M | $17.2M | |
| Common stock, par value (in dollars per share) | $0.01 | $0.01 | |
| Common stock, authorized (in shares) | 750.0M shares | 750.0M shares | |
| Common stock, issued (in shares) | 528.2M shares | 523.6M shares | |
| Common stock, outstanding (in shares) | 528.2M shares | 523.6M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years, latest first.5
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net income (loss) | -$908.0K | $8.6K |
| Depreciation and amortization | $402.4K | $401.1K |
| Gain on disposal of property, plant, and equipment | $0 | -$13.5K |
| Accretion of obligation for lease disposal costs | $73.7K | $70.3K |
| Equity based compensation | $117.8K | $199.4K |
| Right-of-use asset changes, net | $16.6K | -$4.5K |
| Accounts receivable | $103.1K | -$52.1K |
| Prepaids and other current assets | $61.5K | -$25.1K |
| Inventories | -$54.6K | $106.2K |
| Accounts payable and accrued liabilities | $931.9K | $367.7K |
| Unearned revenues | -$124.4K | -$419.4K |
| Net cash provided by operating activities | $620.2K | $638.8K |
| Proceeds from sale of property, plant, and equipment | $0 | $36.0K |
| Purchase of property, plant, equipment, and patents | -$534.2K | -$721.2K |
| Net cash used in investing activities | -$534.2K | -$685.2K |
| Proceeds from sale of stock | $20.3K | $12.0K |
| Payments on financing lease liability | $0 | -$2.8K |
| Principal payments on notes payable | -$296.1K | -$154.4K |
| Net cash used in financing activities | -$275.9K | -$145.2K |
| Net decrease in cash and cash equivalents and restricted cash | -$189.8K | -$191.7K |
| Cash paid for interest | $161.0K | $162.6K |
| Cash paid for taxes | $6.7K | $10.1K |
| Property acquired in exchange for a note payable | $45.5K | $315.2K |
| Increase in operating lease right-of-use asset and right-of-use liability for new lease | $992.8K | $0 |
No quarter-by-quarter statement was filed.
Corporate structure
RADNOSTIX INC sits at the top of its group. 7 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of RADNOSTIX INC
- Kennerman Associates, Inc. Filed SCHEDULE 13G on RADNOSTIX INC, latest May 14, 2026 (5 filings since May 2, 2022)
- RADNOSTIX INC Idaho Falls, Idaho
- International Isotopes Fluorine Products Inc. Subsidiary · Idaho, United States
- International Isotopes Idaho Inc. Subsidiary · Idaho, United States
- International Isotopes Transportation Services Inc. Subsidiary · Idaho, United States
- RadQual, LLC Subsidiary · Idaho, United States
- RadVent, LLC Subsidiary · Idaho, United States
- TI Services, LLC Subsidiary · Ohio, United States
Built from subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What RADNOSTIX INC reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Property and equipment, before depreciation | $7.0M5 Dec 31, 2025 | $6.4M5 Dec 31, 2024 | +9.0% |
| Accumulated depreciation | $3.3M5 Dec 31, 2025 | $3.1M5 Dec 31, 2024 | +6.0% |
| Property and equipment, net | $3.7M5 Dec 31, 2025 | $3.3M5 Dec 31, 2024 | +11.9% |
| Finance-lease assets | $05 Dec 31, 2025 | $8265 Dec 31, 2024 | −100.0% |
| Operating-lease assets (leased space) | $2.8M5 Dec 31, 2025 | $2.0M5 Dec 31, 2024 | +39.0% |
Investments
Intangibles and goodwill
| Item | Latest | A year before | Change |
|---|---|---|---|
| Goodwill | $1.4M5 Dec 31, 2025 | $1.4M5 Dec 31, 2024 | 0% |
| Finite-lived intangibles, gross | $5.4M5 Dec 31, 2025 | $5.4M5 Dec 31, 2024 | 0% |
| Accumulated amortization | $2.2M5 Dec 31, 2025 | $2.0M5 Dec 31, 2024 | +8.3% |
| Finite-lived intangibles, net | $3.2M5 Dec 31, 2025 | $3.4M5 Dec 31, 2024 | −4.9% |
Inventory
Properties, in its own words
In 2001, we leased one property in Idaho ("Building A") which serves as or main corporate headquarters and houses all of our current manufacturing operations for our core business segments. Our TI Services subsidiary leases an office facility in Ohio. In December 2024, we purchased vacant land adjacent to our main corporate headquarters. We also hold the conditional title to 640 acres of land in Lea County, New Mexico for the proposed de-conversion facility. The following paragraphs provide a brief summary of these properties. Beginning in January 2025, we began leasing a second facility across the street from our main headquarters ("Building B").
Building A: 4137 Commerce Circle, Idaho Falls, Idaho – The facility located on this property houses our main corporate headquarters and all of our current manufacturing operations. In January 2020, we entered into a new lease agreement due to new and expanded facilities made available to us. The initial lease term is until January 2030 and provides an option to renew for an additional 5 years. The facility was new when leased in March 2001 and remains in excellent condition. We have the right of first refusal on this property that allows us to match any offer to purchase this property.
The rest of Item 2
Building B: 1359 Commerce Way, Idaho Falls, Idaho – This facility is located directly across the street from Building A. We began leasing this facility in January 2025; the initial term is until December 2029 and we have the option to extend the lease for two additional terms of 5 years each. We have the right of first refusal on this property that allows us to match any offer to purchase this property.
775 Boardman-Canfield Rd, Unit A-2, Boardman, Ohio – This office facility houses the employees of TI Services who are engaged in sales activities. The facility was leased in November 2017 and is currently under tenancy from month-to-month.
Land Adjacent to Building A, Idaho Falls, Idaho – Land is located directly South of Building A; it was acquired in December 2024 through a mix of cash and seller's financing. The land has no zoning restrictions in regards to building coverage and height.
Item 2 of the 10-K filed Mar 31, 2026.4
Leadership
Who has led RADNOSTIX INC, and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
- Chief executive officerShahe Bagerdjian Sep 7, 2023 to now14
- Chief executive officerSteve Laflin Aug 14, 2007 to May 1, 202315
- PresidentShahe Bagerdjian May 12, 2023 to Aug 29, 202316
- Chief financial officerW. Matthew Cox Oct 3, 2019 to Nov 22, 202417
- Chief financial officerLaurie McKenzie-Carter Sep 22, 2009 to May 3, 201918
Board members and other officers (5)
- Board memberShahe Bagerdjian Aug 29, 2023 to now19
- Board memberRobert Atcher Aug 18, 2017 to now20
- Board memberSteve Laflin Aug 14, 2007 to now15
- Board memberRalph M. Richart Feb 7, 2006 to Feb 22, 201721
- Board memberChristopher G. Grosso Aug 17, 2006 to now22
Subsidiaries and ownership
Subsidiaries (Exhibit 21)
- International Isotopes Fluorine Products Inc. Idaho3
- International Isotopes Idaho Inc. Idaho3
- International Isotopes Transportation Services Inc. Idaho3
- RadQual, LLC Idaho3
- RadVent, LLC Idaho3
- TI Services, LLC Ohio3
The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.
Former names
- INTERNATIONAL ISOTOPES INCOct 3, 1997 to Dec 31, 20252
Timeline
- Oct 1, 20268-K Entered a material agreement; Regulation FD disclosure23
- Jul 21, 20268-K Executive or director change; Shareholder vote24
- Jul 1, 20268-K Entered a material agreement; Completed an acquisition or sale; New debt or obligation25
- May 20, 20268-K Change to shareholders' rights; Bylaws or fiscal year changed26
- Mar 16, 20268-K Ended a material agreement; Other events27
- Dec 31, 20258-K Bylaws or fiscal year changed; Other events28
- Oct 17, 20258-K Executive or director change; Bylaws or fiscal year changed29
- Oct 17, 20258-K Executive or director change; Bylaws or fiscal year changed30
- Jul 16, 20258-K Shareholder vote31
- Oct 2, 20248-K Change to shareholders' rights; Bylaws or fiscal year changed32
- Jul 16, 20248-K Shareholder vote33
- Feb 8, 20248-K Entered a material agreement; Regulation FD disclosure34
- Sep 7, 2023New chief executive Shahe Bagerdjian becomes CEO14
- Aug 14, 2007New chief executive Steve Laflin becomes CEO15
Filings
93 filings to the SEC since October 2021: 8 annual reports, 15 quarterly reports, 19 major events, 31 insider forms, 5 large holders, 15 other. The latest 20:
- Oct 1, 20268-K EDGAR
- Aug 26, 2026S-8 EDGAR
- Aug 12, 202610-Q EDGAR
- Jul 21, 20268-K EDGAR
- Jul 1, 20268-K EDGAR
- Jun 30, 20264 EDGAR
- Jun 4, 2026DEFA14A EDGAR
- Jun 4, 2026DEF 14A EDGAR
- May 20, 20268-K EDGAR
- May 20, 202610-Q EDGAR
- May 15, 2026NT 10-Q EDGAR
- May 14, 2026SCHEDULE 13G EDGAR
- Apr 30, 20264 EDGAR
- Apr 30, 202610-K/A EDGAR
- Mar 31, 202610-K EDGAR
- Mar 16, 20268-K EDGAR
- Dec 31, 20258-K EDGAR
- Nov 26, 2025DEF 14C EDGAR
- Nov 14, 202510-Q EDGAR
- Oct 17, 20258-K EDGAR
The 93 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
13 open-market trades by officers, directors and large owners since October 2021: 13 buys and 0 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| May 22, 2025 | Bagerdjian ShahePres. & CEO | Buy | 140,000 | $0.05 | $7.0K | Form 4 |
| Mar 6, 2025 | Bagerdjian ShahePres. & CEO | Buy | 177,000 | $0.05 | $8.8K | Form 4 |
| Nov 22, 2024 | COX W MATTHEWChief Financial Officer | Buy | 60,000 | $0.03 | $1.8K | Form 4 |
| Nov 20, 2024 | Bagerdjian ShahePres. & CEO | Buy | 100,000 | $0.04 | $4.0K | Form 4 |
| Nov 20, 2024 | COX W MATTHEWChief Financial Officer | Buy | 30,000 | $0.04 | $1.2K | Form 4 |
| Nov 14, 2024 | GROSSO CHRISTOPHER GDirector | Buy | 401,117 | $0.03 | $12.0K | Form 4 |
| Sep 18, 2024 | GROSSO CHRISTOPHER GDirector | Buy | 800,000 | $0.03 | $24.0K | Form 4 |
| Jun 14, 2024 | Bagerdjian ShahePres. & CEO | Buy | 250,000 | $0.04 | $10.0K | Form 4 |
| Jun 14, 2024 | COX W MATTHEWChief Financial Officer | Buy | 239,669 | $0.04 | $9.6K | Form 4 |
| Dec 14, 2023 | COX W MATTHEWChief Financial Officer | Buy | 250,000 | $0.03 | $7.5K | Form 4 |
| Dec 14, 2023 | Bagerdjian ShahePres. & CEO | Buy | 1,000,000 | $0.03 | $30.0K | Form 4 |
| Aug 25, 2023 | Bagerdjian ShahePres. & CEO | Buy | 3,950 | $0.05 | $198 | Form 4 |
| Nov 15, 2022 | GROSSO CHRISTOPHER GDirector | Buy | 1,410,000 | $0.03 | $42.3K | Form 4 |
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Kennerman Associates, Inc.SCHEDULE 13G, 5 filings May 2, 2022 to May 14, 202635
Executive pay
What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.
| Year | Executive | Age | Salary | Total pay |
|---|---|---|---|---|
| 2025 | Shahe Bagerdjian | 42 | $309.2K | $1.5M36 |
| 2025 | W. Matthew Cox | 42 | $161.9K | $172.7K36 |
| 2024 | PresidentChief Executive Officer | $294.6K | $429.7K36 | |
| 2024 | Chief Financial Officer and Secretary | $147.4K | $148.7K36 |
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| Capital Square, LLC | 20,000 | $1.3K | 0.0% | No change |
13F reports cover disclosed long positions in U.S. stocks only.
SEC filer profile
How RADNOSTIX INC is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARRADNOSTIX INC1
- CIK0001038277
- Employer ID (EIN)74-27638374
- Filer statusNon-accelerated filer not an emerging growth company; a smaller reporting company; not a shell company4
- Incorporated inTexas4
- Fiscal year endsDecember 311
- Industry code (SIC)3823 Industrial Instruments For Measurement, Display, and Control1
- SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
- Business address4137 Commerce Circle, Idaho Falls, ID 834011
- Phone20852453001
- Shares outstanding529,154,204 as of Aug 10, 202612
- Public float$6.0M as of Jun 30, 20254
- AuditorHaynie, Salt Lake City, UT PCAOB ID 457; no auditor attestation of internal control over financial reporting4
- On EDGAR sinceMay 1, 19971
- Filings543 in all: 4 (124), 8-K (99), 10-Q (67), DEF 14A (31), SC 13G/A (23), 10-K (21), 10QSB (21), S-8 (9)1
All 54 form types
SC 13D/A (9), 424B3 (8), PRE 14A (8), S-3 (8), 10-K/A (7), 10KSB (7), NT 10-Q (7), POS AM (7), CORRESP (6), CT ORDER (6), D (5), EFFECT (5), NT 10-K (5), UPLOAD (5), 3 (4), DEFA14A (4), SC 13G (4), 10QSB/A (3), 5 (3), S-3/A (3), SB-2/A (3), 10KSB/A (2), 4/A (2), 8-K/A (2), AW (2), SB-2 (2), SC 13D (2), 10-K405 (1), 10-Q/A (1), 424B2 (1), 424B4 (1), 8-A12B (1), 8-A12G (1), DEF 14C (1), DEFR14A (1), DEFS14A (1), NT 10-Q/A (1), NTN 10K (1), PRES14A (1), REGDEX (1), RW (1), S-1 (1), S-1/A (1), S-8 POS (1), SCHEDULE 13G (1), SCHEDULE 13G/A (1)
- Latest filingsAnnual report (10-K) Mar 31, 2026
Quarterly report (10-Q) Aug 12, 2026
Proxy statement (DEF 14A) Jun 4, 2026
Latest 8-K (8-K) Oct 1, 2026
Risk factors and legal proceedings
The risks RADNOSTIX INC names in Item 1A of its 10-K filed Mar 31, 2026: 5 risks under these headings, as written.4
- Readers should carefully consider the following factors that may affect our business, future operating results, and financial condition, as well as other information included in this Annual Report. The risks and uncertainties described below are not the only ones the Company faces. Additional risks and uncertainties not presently known to us or that we currently deem immaterial also may impair our business operations. If any of the following risks occur, our business, financial condition results of operations, or cash flow could be materially adversely affected.
- Risks Related To Our Company
- All our manufacturing processes generate some radioactive waste that is expensive to dispose of safely.
- We are subject to extensive health and safety regulations.
- We are subject to various federal, state, local and foreign government requirements regulating the discharge of materials into the environment or otherwise relating to the protection of the environment.
- We are subject to significant regulatory oversight of our import and export operations due to the nature of our product offerings.
- Risks Related To Our Common Stock
Legal proceedings
From time to time, we may become party to litigation or other legal proceedings that we consider to be a part of the ordinary course of our business. We are not currently involved in legal proceedings that could reasonably be expected to have a material adverse effect on our business, prospects, financial condition, or results of operations. We may become involved in material legal proceedings in the future.
The opening of Item 3, Legal Proceedings.4
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARRADNOSTIX INC filings on SEC EDGAR
- 2SEC EDGARRADNOSTIX INC filings on SEC EDGAR
- 3
- 4
- 5SEC EDGARRADNOSTIX INC 10-K for fiscal 2025
- 6SEC EDGARRADNOSTIX INC 10-K for fiscal 2019
- 7SEC EDGARRADNOSTIX INC 10-K for fiscal 2020
- 8SEC EDGARRADNOSTIX INC 10-K for fiscal 2021
- 9SEC EDGARRADNOSTIX INC 10-K for fiscal 2022
- 10SEC EDGARRADNOSTIX INC 10-K for fiscal 2023
- 11SEC EDGARRADNOSTIX INC 10-Q for fiscal 2026
- 12SEC EDGARRADNOSTIX INC 10-Q for fiscal 2026
- 13SEC EDGARRADNOSTIX INC 10-K for fiscal 2019
- 14
- 15
- 16SEC EDGARShahe Bagerdjian, President
- 17
- 18
- 19SEC EDGARShahe Bagerdjian, Board member
- 20SEC EDGARRobert Atcher, Board member
- 21SEC EDGARRalph M. Richart, Board member
- 22SEC EDGARChristopher G. Grosso, Board member
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31SEC EDGARShareholder vote
- 32
- 33SEC EDGARShareholder vote
- 34
- 35
- 36